Translational research associated with 'An investigator-initiated phase II trial of niraparib for patients with BRCA-mutated unresectable/recurrent biliary tract, pancreatic and other gastrointestinal cancer'
Not Applicable
Recruiting
- Conditions
- biliary tract, pancreatic and other gastrointestinal cancers
- Registration Number
- JPRN-UMIN000049452
- Lead Sponsor
- Hokkaido University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
None
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Protein expression analysis
- Secondary Outcome Measures
Name Time Method Cancer-related genetic analysis